These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35938736)

  • 1. Comparison of circulating miR-148a and miR-126 with autoantibodies as biomarkers of lupus nephritis in patients with SLE.
    Omidi F; Khoshmirsafa M; Kianmehr N; Faraji F; Delbandi A; Seif F; Shekarabi M
    J Immunoassay Immunochem; 2022 Nov; 43(6):634-647. PubMed ID: 35938736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
    J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.
    Chi S; Yu Y; Shi J; Zhang Y; Yang J; Yang L; Liu X
    Dis Markers; 2015; 2015():450351. PubMed ID: 26549923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus.
    Li W; Liu S; Chen Y; Weng R; Zhang K; He X; He C
    Clinics (Sao Paulo); 2020; 75():e1528. PubMed ID: 32876110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
    Zhang CQ; Ren L; Gao F; Mu FY; You YQ; Liu YH
    Clin Rheumatol; 2011 Jul; 30(7):967-73. PubMed ID: 21340499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
    Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
    J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G; Al-Barshomy SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.
    Sjöwall C; Bentow C; Aure MA; Mahler M
    J Immunol Res; 2018; 2018():1294680. PubMed ID: 30246032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal microRNAs as biomarkers of lupus nephritis.
    Chen F; Shi B; Liu W; Gong J; Gao J; Sun Y; Yang P
    Front Immunol; 2023; 14():1326836. PubMed ID: 38223506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children].
    Li YZ; Yang JR; Zhang YD; Cao Y; Li XY; Shuai LJ; Wang Y; Shen T; Wu XC
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug; 26(8):835-839. PubMed ID: 39148388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y; Wu X; Shan G; Zhang X
    Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.